Dr. Paolo Bossi
IRCCS Foundation, National Cancer Institute, Italy
Head and neck cancer, from transnational research (gene expression, next generation sequencing) to assessment of quality of life and value based medicine. He is particularly dedicated to rare cancer among head and neck ones(paranasal sinus cancer, adnexal cancer, nasopharyngeal cancer, salivary gland cancer). He has a strong commitment to supportive care, specifically for what concerns mucositis induced by cancer therapies. He collaborates to the Italian Network on Rare Tumors, a collaborative effort among Italian cancer centers, which tries to exploit distant patient sharing in order to improve quality of care and diminish health migration for rare solid cancers.